Healthcare
Fielmann AG(FLMNY)
Live Price
Offline$9.94
+0.00% today
1Y Change
-22.38%
Window
Jun 25, 2025 โ Jun 23, 2026
- Market Cap
- $3.57B
- Revenue Growth
- +3.3%
- EPS Growth
- +29.3%
- Dividend Yield
- 2.7%
Coverage: 254 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Fielmann AG (FLMNY) is a Healthcare stock with a market cap of $3.57B and listed on OTC. The stock last traded around $9.94 and down 22.4% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of +3.3%, EPS growth of +29.3%, a dividend yield of 2.7%. What stands out right now is revenue +3.3%, EPS +29.3%, free cash flow +3.3% with operating margin 13.3% and ROIC 11.8%. The dividend matters to the case here, with a current yield around 2.7%. Valuation is more restrained than many high-expectation growth names at P/E 17.5 and price/sales 1.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines FLMNY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+3.3% vs +7.6% peer median
Operating Margin
Below sector median
+13.3% vs +19.4% peer median
P/E
Below sector median
17.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +3.3% and EPS at +29.3%, with operating margin around 13.3%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.9% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | +0.0% | +0.0% | +0.0% |
2026 Mar 2, 2026 | โ | +0.0% | -5.7% | -5.7% |
2025 Nov 6, 2025 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Edge
FLMNY vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
FLMNY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
FLMNY Max Drawdown
-32.96%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for FLMNY and SPY.
Company Overview
Fielmann AG
Other OTC
Fielmann Aktiengesellschaft, together with its subsidiaries, engages in the investment in and operation of optical and hearing aid businesses. The company manufactures and sells visual aids and other optical products, including glasses, frames, lenses, sunglasses, contact lenses and accessories, and various merchandise, as well as hearing aids and accessories. As of December 31, 2021, it operated 693 stores, including 610 in Germany, 45 in Switzerland, 38 Austria, 3 in Luxembourg, 43 in Italy, 37 in Poland, 87 in Spain, 32 in Slovenia, and 15 in the rest of Europe. The company also 78 smaller locations in Eastern Europe. It also offers its products through online stores. The company was founded in 1972 and is headquartered in Hamburg, Germany. Fielmann Aktiengesellschaft is a subsidiary of Korva SE.
- Leadership
- Marc Fielmann
- IPO Date
- Mar 21, 2017
- Employees
- 20.2k
- Street Address
- Weidestrasse 118a
- Mailing
- Hamburg, 22083
- Region
- Hamburg, DE
- Reporting Currency
- USD
- Investor Line
- 49 40 27076 0
- Last Updated
- Apr 29, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 17.5
- EV/EBITDA
- 7.1
- Price/Sales
- 1.5
- Price/Book
- 3.7
Growth
- Revenue
- +3.3%
- EPS
- +29.3%
- Free Cash Flow
- +3.3%
Profitability
- Gross Margin
- 26.9%
- Operating Margin
- 13.3%
- Net Margin
- 8.4%
- ROE
- 22.1%
- ROIC
- 11.8%
Balance Sheet
- Debt/Equity
- 0.57
- Current Ratio
- 1.15
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.